These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15791509)

  • 61. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
    Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
    J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Obesity and left ventricular assist device driveline exit site infection.
    Raymond AL; Kfoury AG; Bishop CJ; Davis ES; Goebel KM; Stoker S; Selzman CH; Clayson SE; Smith H; Cowley CG; Alharethi R; Budge D; Reid BB
    ASAIO J; 2010; 56(1):57-60. PubMed ID: 20051832
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ventricular arrhythmias during left ventricular assist device support.
    Bedi M; Kormos R; Winowich S; McNamara DM; Mathier MA; Murali S
    Am J Cardiol; 2007 Apr; 99(8):1151-3. PubMed ID: 17437746
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device.
    Schofield RS; Pierce GL; Nichols WW; Klodell CT; Aranda JM; Pauly DF; Hill JA; Braith RW
    Am J Hypertens; 2007 Jun; 20(6):622-8. PubMed ID: 17531918
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved long-term performance of pulsatile extracorporeal left ventricular assist device.
    Sasaoka T; Kato TS; Komamura K; Takahashi A; Nakajima I; Oda N; Hanatani A; Mano A; Asakura M; Hashimura K; Niwaya K; Funatsu T; Kobayashi J; Kitamura S; Shishido T; Wada K; Miyata S; Nakatani T; Isobe M; Kitakaze M
    J Cardiol; 2010 Sep; 56(2):220-8. PubMed ID: 20615667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of age on outcomes after left ventricular assist device placement.
    Huang R; Deng M; Rogers JG; Howser R; Portner PM; Pierson RN; Butler J
    Transplant Proc; 2006 Jun; 38(5):1496-8. PubMed ID: 16797341
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Outcomes of Heart Transplant After Left Ventricular Assist Device Specific and Related Infection.
    Tong MZ; Smedira NG; Soltesz EG; Starling RC; Koval CE; Porepa L; Moazami N
    Ann Thorac Surg; 2015 Oct; 100(4):1292-7. PubMed ID: 26188972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changing trends in mechanical circulatory assistance:
    Rao V; Oz MC; Flannery MA; Idrissi KA; Argenziano M; Edwards NM; Naka Y
    J Card Surg; 2004; 19(4):361-6. PubMed ID: 15245472
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation.
    Filsoufi F; Rahmanian PB; Castillo JG; Pinney S; Broumand SR; Adams DH
    J Heart Lung Transplant; 2007 Nov; 26(11):1084-90. PubMed ID: 18022072
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.
    Yamani MH; Chuang HH; Ozduran V; Avery RK; Mawhorter SD; Cook DJ; Zilka C; Zeroske K; Buda T; Hobbs RE; Taylor DO; Smedira NG; Starling RC
    J Heart Lung Transplant; 2006 Jul; 25(7):820-4. PubMed ID: 16818125
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Surgical infection prophylaxis for left ventricular assist device implantation.
    Walker PC; DePestel DD; Miles NA; Malani PN
    J Card Surg; 2011 Jul; 26(4):440-3. PubMed ID: 21554393
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.
    Russo MJ; Hong KN; Davies RR; Chen JM; Sorabella RA; Ascheim DD; Williams MR; Gelijns AC; Stewart AS; Argenziano M; Naka Y
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1425-32.e1-3. PubMed ID: 19931672
    [TBL] [Abstract][Full Text] [Related]  

  • 77. European results with a continuous-flow ventricular assist device for advanced heart-failure patients.
    Lahpor J; Khaghani A; Hetzer R; Pavie A; Friedrich I; Sander K; Strüber M
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):357-61. PubMed ID: 19616963
    [TBL] [Abstract][Full Text] [Related]  

  • 78. One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation.
    Robertson JO; Lober C; Smedira NG; Navia JL; Sopko N; Gonzalez-Stawinski GV
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):295-300. PubMed ID: 18539472
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.
    Dang NC; Topkara VK; Kim BT; Mercando ML; Kay J; Naka Y
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1302-9. PubMed ID: 16256782
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.